Soft Mist™ Technology delivers medication in a slow moving mist. Pro-drug activated in the airway epithelium. Activated prodrug
has 12x greater glucocorticoid receptor affinity than dexamethasone. No statistically significant decrease in serum cortisol.
Accepted by >93% of horses. Proven safety and efficacy under controlled and field conditions in over 600 horses. A novel
glucocorticoid that is activated in the lower airway into the potent anti-inflammatory des-ciclesonide for management of severe
equiine asthma. The Soft Mist™ inhaler provides high fine particle fraction for deep peripheral lung deposition, low velocity
stream for easy inhalation and predetermined dosing for accurate delivery. The nostril adapter fits gently inside the left nostril
of the horse, while the BreathView® indicator allows the user to time the generation of the mist with the beginning of inhalation,
the inhaler is ergonomically designed for left hand use, allowing the right hand to remain free to comfort the horse. Nostril
adapter - snug fit in the left nostril serves as reservoir for the drug. BreathView® breath indicator - easy timing with beginning
of inhalation. Single use - minimizes risk for cross contamination between horses. Single hand maneuver - second hand is free to
aid in handling the horse. Simple treatment protocol - 1 dose fits all. Fill indicator - easy monitoring of drug solution level.
For the alleviation of clinical symptoms of severe equine asthma characterized by coughing, nasal discharge, nasal flaring,
increased breathing effort at rest, or abnormal lung sounds.